An increase in the usage of albumin as a multifunctional excipient, a shift toward the usage of recombinant albumin, and a grant of regulatory approvals.
/PRNewswire/ The global albumin market was valued around US$ 891.7 Mn in 2020. The global market is anticipated to rise at a CAGR of 6.2% from 2021 to 2028..
/PRNewswire/ The global albumin market was valued around US$ 891.7 Mn in 2020. The global market is anticipated to rise at a CAGR of 6.2% from 2021 to 2028..
- It is utilized as a medication carrier in treating cancer, diabetes, rheumatoid arthritis, and hepatitis, which is expected to drive the global albumin (as excipient) market - The market